Enhancing Patterns in Multiple Sclerosis: Evolution and Persistence

References

1. ↵
   Grossman RI, McGowan JC. Perspectives on multiple sclerosis. AJNR Am J Neuroradiol 1998;19:1251-1265

   PubMedWeb of Science
2. Fazekas F, Barkhof F, Filippi M, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999;53:448-456

   Abstract/FREE Full Text
3. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24

   Abstract/FREE Full Text
4. ↵
   Simon JH. Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis. J Magn Reson Imaging 1997;7:29-37

   PubMedWeb of Science
5. ↵
   Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16

   CrossRefPubMedWeb of Science
6. Barkhof F, Scheltens P, Frequin ST, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992;159:1041-1047

   CrossRefPubMedWeb of Science
7. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62

   CrossRefPubMedWeb of Science
8. ↵
   Koudriavtseva T, Thompson AJ, Fiorelli M, et al. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:285-287

   Abstract/FREE Full Text
9. Filippi M, Rocca MA, Horsfield MA, Comi G. A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads. J Neurol Sci 1998;158:203-208

   CrossRefPubMedWeb of Science
10. ↵
    Poser CM, Paty DW, Scheinberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231

    CrossRefPubMedWeb of Science
11. ↵
    Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041-1049

    Abstract
12. ↵
    Simon JH. From enhancing lesions to brain atrophy in relapsing MS. J Neuroimmunol 1999;98:7-15

    CrossRefPubMedWeb of Science
13. ↵
    Kappos L, Moeri D, Radue WE, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Lancet 1999;353:964-969

    CrossRefPubMedWeb of Science
14. ↵
    Guttmann CRG, AHN SS, Hsu L, Kikinis R, Jolesz FA. The evolution of multiple sclerosis lesions on serial MR. AJNR Am J Neuroradiol 1995;16:1481-1491

    Abstract
15. ↵
    Hickey WF. The pathology of multiple sclerosis: a historical perspective. J Neuroimmunol 1999;98:37-44

    CrossRefPubMedWeb of Science
16. Raine CS. Part two—neuropathology and etipathogenesis. In: Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple Sclerosis: Clinical and Pathogenic Basis. London, New York: Chapman & Hall Medical 1997;159-170
17. ↵
    Bastianello S, Pozzilli C, Bernardi S, et al. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology 1990;40:591-595

    Abstract/FREE Full Text
18. Filippi M, Rocca MA, Sormani MP, Pereira C, Comi G. Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging. Magn Reson Imaging 1999;17:979-984

    CrossRefPubMedWeb of Science
19. ↵
    Rovira A, Alonso J, Cucurella G, et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol 1999;20:1939-1945

    Abstract/FREE Full Text
20. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491

    PubMedWeb of Science
21. Hiehle JF, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison of gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77

    Abstract
22. ↵
    Harris JO, Frank JA, Patronas N, McFarlin DE, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548-555

    CrossRefPubMedWeb of Science
23. ↵
    Kwon EE, Prineas JW. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropathol Exp Neurol 1994;53:625-636

    PubMedWeb of Science
24. ↵
    Claudio L, Raine CS, Brosnan CF. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol 1995;90:228-238

    PubMed
25. ↵
    Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Multiple sclerosis disease activity correlates with gadolinium enhanced magnetic resonance imaging. Ann Neurol 1987;21:300-306

    CrossRefPubMedWeb of Science
26. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991;114:1271-1280

    Abstract/FREE Full Text
27. Filippi M, Rossi P, Campi A, Colombo B, Pereira C, Comi G. Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability. AJNR Am J Neuroradiol 1997;18:1549-1556

    Abstract
28. ↵
    Rosenblum D, Saffir M. The natural history of multiple sclerosis and its diagnosis. Phys Rehabil Clin N Am 1998;9:537-549
29. ↵
    Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467-474

    PubMedWeb of Science
30. ↵
    Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 1996;46:379-384

    Abstract/FREE Full Text
31. ↵
    Rovaris M, Mastronardo G, Prandini F, Bastianello S, Comi G, Filippi M. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans. J Neurol Sci 1999;164:148-152

    CrossRefPubMedWeb of Science
32. ↵
    Rovaris M, Rodegher M, Comi G. Filippi M. Correlation between MRI and short-term clinical activity in multiple sclerosis: comparison between standard- and triple-dose Gd-enhanced MRI. Eur Neurol 1999;41:123-127

    CrossRefPubMedWeb of Science